Umbilical Cord Blood Therapy Potentiated with Erythropoietin for Children with Cerebral Palsy: A Double-blind, Randomized, Placebo-Controlled Trial

Abstract

Allogeneic umbilical cord blood (UCB) has therapeutic potential for cerebral palsy (CP). Concomitant administration of recombinant human erythropoietin (rhEPO) may boost the efficacy of UCB, as it has neurotrophic effects. The objectives of this study were to assess the safety and efficacy of allogeneic UCB potentiated with rhEPO in children with CP. Children with CP were randomly assigned to one of three parallel groups: the pUCB group, which received allogeneic UCB potentiated with rhEPO; the EPO group, which received rhEPO and placebo UCB; and the Control group, which received placebo UCB and placebo rhEPO. All participants received rehabilitation therapy. The main outcomes were changes in scores on the following measures during the 6 months treatment period: the gross motor performance measure (GMPM), gross motor function measure, and Bayley scales of infant development-II (BSID-II) Mental and Motor scales (18). F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET/CT) and diffusion tensor images (DTI) were acquired at baseline and followed up to detect changes in the brain. In total, 96 subjects completed the study. Compared with the EPO (n = 33) and Control (n = 32) groups, the pUCB (n = 31) group had significantly higher scores on the GMPM and BSID-II Mental and Motor scales at 6 months. DTI revealed significant correlations between the GMPM increment and changes in fractional anisotropy in the pUCB group. 18F-FDG-PET/CT showed differential activation and deactivation patterns between the three groups. The incidence of serious adverse events did not differ between groups. In conclusion, UCB treatment ameliorated motor and cognitive dysfunction in children with CP undergoing active rehabilitation, accompanied by structural and metabolic changes in the brain.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 57

1. 1.

   Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol. 2005;47:571-576.

   Not in our library10.1017/s001216220500112x

2. 2.

   Aisen ML, Kerkovich D, Mast J, et al. Cerebral palsy: Clinical care and neurological rehabilitation. Lancet Neurol. 2011;10:844-852.

   Not in our library10.1016/s1474-4422(11)70176-4

3. 3.

   Patel DR, Greydanus DE, Calles JL, et al. Developmental disabilities across the lifespan. Dis Mon. 2010;56:304-397.

   Not in our library10.1016/j.disamonth.2010.02.001

4. 4.

   Carroll JE, Mays RW. Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther. 2011;11:463-471.

   Not in our library10.1517/14712598.2011.557060

5. 5.

   Lee MW, Jang IK, Yoo KH, et al. Stem and progenitor cells in human umbilical cord blood. Int J Hematol. 2010;92:45-51.

   Not in our library10.1007/s12185-010-0619-4

6. 6.

   Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178.

   Not in our library10.1056/nejm198910263211707

7. 7.

   Kurtzberg J. Update on umbilical cord blood transplantation. Curr Opin Pediatr. 2009;21:22-29.

   Not in our library10.1097/mop.0b013e32832130bc

8. 8.

   Vendrame M, Cassady J, Newcomb J, et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004;35:2390-2395.

   Not in our library10.1161/01.str.0000141681.06735.9b

9. 9.

   Nan Z, Grande A, Sanberg CD, et al. Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann N Y Acad Sci. 2005;1049:84-96.

   Not in our library10.1196/annals.1334.009

10. 10.

    Lu D, Sanberg PR, Mahmood A, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002;11:275-281.

    Not in our library

11. 11.

    Nikolic WV, Hou H, Town T, et al. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev. 2008;17:423-439.

    Not in our library10.1089/scd.2008.0018

12. 12.

    Meier C, Middelanis J, Wasielewski B, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006;59:244-249.

    Not in our library10.1203/01.pdr.0000197309.08852.f5

13. 13.

    Papadopoulos KI, Low SS, Aw TC, et al. Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections. Restor Neurol Neurosci. 2011;29:17-22.

    Not in our library10.3233/rnn-2011-0572

14. 14.

    Sun J, Allison J, McLaughlin C, et al. Differences in quality between privately and publicly banked umbilical cord blood units: A pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion. 2010;50:1980-1987.

    Not in our library10.1111/j.1537-2995.2010.02720.x

15. 15.

    Cox CS, Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68:588-600.

    Not in our library10.1227/neu.0b013e318207734c

16. 16.

    Liu WS, Chen CT, Foo NH, et al. Human umbilical cord blood cells protect against hypothalamic apoptosis and systemic inflammation response during heatstroke in rats. Pediatr Neonatol. 2009;50:208-216.

    Not in our library10.1016/s1875-9572(09)60065-6

17. 17.

    Vexler ZS, Yenari MA. Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci. 2009;31:378-393.

    Not in our library10.1159/000232556

18. 18.

    Lin CY, Chang YC, Wang ST, et al. Altered inflammatory responses in preterm children with cerebral palsy. Ann Neurol. 2010;68:204-212.

    Not in our library10.1002/ana.22049

19. 19.

    Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069-2081.

    Not in our library10.1056/nejmoa042604

20. 20.

    Sorror ML, Maris MB, Storer B, et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: Influence of pretransplantation comorbidities. Blood. 2004;104:961-968.

    Not in our library10.1182/blood-2004-02-0545

21. 21.

    Jing M, Shingo T, Yasuhara T, et al. The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting. Brain Res. 2009;1295:203-217.

    Not in our library10.1016/j.brainres.2009.07.079

22. 22.

    Luo J, Zhang HT, Jiang XD, et al. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir (Wien). 2009;151:1483-1492.

    Not in our library10.1007/s00701-009-0402-6

23. 23.

    Chen J, Li Y, Chopp M. Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology. 2000;39:711-716.

    Not in our library10.1016/s0028-3908(00)00006-x

24. 24.

    Wustenberg T, Begemann M, Bartels C, et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry. 2011;16:26-36.

    Not in our library10.1038/mp.2010.51

25. 25.

    Siren AL, Fasshauer T, Bartels C, et al. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6:108-127.

    Not in our library10.1016/j.nurt.2008.10.041

26. 26.

    Iwai M, Cao G, Yin W, et al. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38:2795-2803.

    Not in our library10.1161/strokeaha.107.483008

27. 27.

    Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41:1032-1037.

    Not in our library10.1161/strokeaha.109.570325

28. 28.

    Keogh CL, Yu SP, Wei L. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther. 2007;322:521-528.

    Not in our library10.1124/jpet.107.121392

29. 29.

    Liu W, Shen Y, Plane JM, et al. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol. 2011;230:227-239.

    Not in our library10.1016/j.expneurol.2011.04.021

30. 30.

    van der Kooij MA, Groenendaal F, Kavelaars A, et al. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev. 2008;59:22-33.

    Not in our library10.1016/j.brainresrev.2008.04.007

31. 31.

    Dasari VR, Veeravalli KK, Saving KL, et al. Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway. Neurobiol Dis. 2008;32:486-498.

    Not in our library10.1016/j.nbd.2008.09.005

32. 32.

    Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119-10122.

    Not in our library10.1073/pnas.92.22.10119

33. 33.

    Boyce WF, Gowland C, Rosenbaum PL, et al. The gross motor performance measure: Validity and responsiveness of a measure of quality of movement. Phys Ther. 1995;75:603-613.

    Not in our library10.1093/ptj/75.7.603

34. 34.

    Russell DJ, Rosenbaum PL, Avery LM, et al. Gross Motor Function Measure (GMFM-66 & GMFM-88) User's Manual. 2002.

    Not in our library

35. 35.

    Bayley N. Bayley Scales of Infant Development. 1993.

    Not in our library

36. 36.

    Haley SM, Coster WJ, Ludlow LH, et al. Pediatric Evaluation of Disability Inventory (PEDI). 1992.

    Not in our library

37. 37.

    Guide for the Uniform Data Set for Medical Rehabilitation for Children (WeeFIM). 1993.

    Not in our library

38. 38.

    DeMatteo CLM, Russell D, Pollock N, et al. QUEST: Quality of Upper Extremity Skills Test Manual. 1992.

    Not in our library

39. 39.

    Nagae LM, Hoon AH, Stashinko E, et al. Diffusion tensor imaging in children with periventricular leukomalacia: Variability of injuries to white matter tracts. Am J Neuroradiol. 2007;28:1213-1222.

    Not in our library10.3174/ajnr.a0534

40. 40.

    Hong JH, Son SM, Jang SH. Identification of spinothalamic tract and its related thalamocortical fibers in human brain. Neurosci Lett. 2010;468:102-105.

    Not in our library10.1016/j.neulet.2009.10.075

Cited by papers we hold 4

• Outcomes of Bone Marrow Mononuclear Cell Transplantation for Neurological Sequelae Due to Intracranial Hemorrhage Incidence in the Neonatal Period: Report of Four Cases · 2020
  Not checked
• Cerebral Palsy—Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention · 2017
  No notice
• Therapy for Cerebral Palsy by Human Umbilical Cord Blood Mesenchymal Stem Cells Transplantation Combined With Basic Rehabilitation Treatment · 2015
  Not checked
• Therapeutic Hypothermia for Neonatal Hypoxic–Ischemic Encephalopathy – Where to from Here? · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.